John H. Tucker - 19 Jan 2023 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role
President and CEO, Director
Signature
/s/ John H. Tucker
Issuer symbol
SCPH
Transactions as of
19 Jan 2023
Net transactions value
+$409,323
Form type
4
Filing time
23 Jan 2023, 16:58:05 UTC
Previous filing
11 Oct 2022
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCPH Common Stock Award $409,323 +66,665 +84% $6.14 145,589 19 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCPH Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 19 Jan 2023 Common Stock 100,000 $6.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of a restricted stock unit ("RSU") award made pursuant to the ScPharmaceuticals Inc. 2017 Stock Option and Incentive Plan. The RSUs vest as to 25% of the shares underlying the RSUs on each of the first four anniversaries of January 1, 2023, such that the RSUs will be fully vested on January 1, 2027.
F2 The option shares vest over a four-year period, at a rate of 25% on January 1, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares will be fully vested on January 1, 2027.

Remarks:

Exhibit 24 - Power of Attorney.